The Chicago Board Options Exchange (Cboe) has submitted a filing to list a staked Injective (INJ) exchange-traded fund (ETF) managed by Canary Capital.
This filing, made via Form 19b-4, seeks to introduce the first regulated US ETF offering exposure to Injective’s native governance token and its staking rewards mechanisms.
If approved by the Securities and Exchange Commission (SEC), the fund would become the third staked crypto-focused ETF available in the United States, following similar products for Solana and Ether.
The move could enhance market liquidity and visibility for INJ, which currently trades significantly below its all-time peak.
It occurs amid a perceived shift in the US regulatory stance, with the SEC recently acknowledging the role of staking within blockchain networks.
The SEC now has up to 240 days from the formal filing date to review the proposal, with a potential final decision timeline extending well into 2026.
Market reactions to previous crypto ETF launches have varied considerably, with Bitcoin’s spot ETF debut correlating with a price surge, while Ethereum’s saw a subsequent decline shortly after approval.